logo
Curious Connection: How Dairy Before Bed Could Haunt Your Sleep

Curious Connection: How Dairy Before Bed Could Haunt Your Sleep

Yahoo06-07-2025
A new study says eating dairy close to bedtime could result in more nightmares.
Researchers in Canada say they have found a link between lactose intolerance and a higher likelihood of experiencing bad dreams. The takeaway: consider avoiding Gouda for a good night's sleep.
The researchers believe that the distress dairy can cause to the stomach of some people can disrupt sleep, inducing more nightmares.
'The results we obtained confirmed our hypothesis that lactose intolerance is indeed predictive of disturbed dreaming and nightmares,' study co-author Russ Powell, a psychologist and professor emeritus at MacEwan University in Edmonton, Alberta, said to Gizmodo.
This is not the first time dairy products, like cheese, have been linked to poor sleep.
The same team behind the latest study previously published a survey that found around one in five participants reported experiencing odd dreams, which they attributed to consuming certain foods or eating late at night. Many of the participants specifically pointed to dairy as the culprit behind their bizarre dreams.
Over 1,000 college students were surveyed for the latest research. Roughly 40% of participants reported that certain foods or late-night snacking affected their sleep, with 25% linking their diet to poor sleep. While only 5.5% of those surveyed this time around blamed foods for affecting their dreams, dairy was among the more common foods singled out.
The researchers also say that people with self-reported lactose intolerance were linked to more severe nightmares and poorer sleep.
'It may be that GI distress, in comparison to other types of physical distress, has a particularly strong impact upon sleeping and dreaming. Menstrual cramping, for example, has also been shown to increase the likelihood of disturbed dreaming,' Powell explained.
He also suspects that, because GI distress can be driven by ingesting poison, nightmares resulting from dairy might be a mechanism the body uses to alert itself in case of a medical emergency.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nootropics Market Size Projected to Attain USD 19.53 Billion by 2034
Nootropics Market Size Projected to Attain USD 19.53 Billion by 2034

Yahoo

time2 hours ago

  • Yahoo

Nootropics Market Size Projected to Attain USD 19.53 Billion by 2034

The global nootropics market is valued at USD 5.71 billion in 2025 and is projected to reach approximately USD 19.53 billion by 2034, expanding at a CAGR of 14.64% during the forecast period. Ottawa, Aug. 14, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global nootropics market size was valued at USD 4.98 billion in 2024 and is projected to reach approximately USD 19.53 billion by 2034, growing at a CAGR of 14.64%. The industry's growth in recent years has been driven by rising awareness of mental health issues. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America dominated the market with the largest market share in 2024. Asia Pacific is anticipated to grow at the fastest rate in the nootropics market over the forecast period. By form, the capsules/tablets segment led the market in 2024. By form, the drinks segment is predicted to witness the fastest growth in the market over the forecast period. By distribution channel, the offline segment dominated the market in 2024. By distribution channel, the online segment is anticipated to grow at the fastest rate in the nootropics market during the forecast period. Market Overview & Potential The increased interest in brain health and mental performance is spearheading the industry growth in recent years. As the younger individuals are contributing significantly to the majorly in this industry by adopting these supplements for the increasing focus, mood, and creativity in the current period. Moreover, the products include ingredients like caffeine, ginseng. L-thenine is more popular in the industry nowadays. What are the Key Growth Drivers Involved in The Expansion of The Market? The rising need for cognitive enhancement among the working professional community is spearheading the industry growth in the current period. Moreover, the nootropic manufacturer are actively looking to create partnerships with the big corporate firms to lead their business in the current period. Furthermore, by providing several advantages such as improved memory, mental energy, and concentration to consumers, the nootropic supplements have gained immense industry attention in recent years. In December 2024, Cristiano Ronaldo invested $15 million in personalised nutrition company Bioniq, increasing the value of the company to $82 million. What Are the Emerging Trends Associated with the Market? The sudden shift towards plant-based and herbal nootropics has driven the industry growth in recent years. The rising popularity of functional beverages, such as drinks with brain-boosting ingredients, has contributed to the industry's growth in the past few years. You can place an order or ask any questions, please feel free to contact us at sales@ Regional Analysis How Did North America Dominate the Market in 2024? In 2024, North America led the nootropics market owing to the increased need for cognitive enhancement in the current period. Moreover, the market growth is mainly associated with factors such as the high awareness and acceptance of the mental wellness supplement in recent years in the region. Furthermore, the greater regulatory push has contributed immensely in the region, as per the recent regional survey. What Made the Asia Pacific Significantly Grow in the Market in 2024? In the nootropics market, the Asia Pacific is predicted to grow at the fastest CAGR during 2025-2034, akin to the rising mental awareness and the development of e-commerce platforms. Moreover, the regional countries such as India, China, and Japan are seen under the sophisticated growth in the wellness market in recent years. Furthermore, the younger population in the region is expected to drive the future growth of the industry, as they are seen as heavy adopters of nootropics for professional and academic performance. Segmental Insights By Form Analysis How did the Capsules and Tablets Segment Dominate the Market in 2024? The capsules and tablets segment held a major share of the nootropic market. Mainly, the segment is driven by its unique properties, such as the convenience, wide availability, and accurate dosage in the current period. Moreover, the individuals are actively seen preferring the tablet forms of the dosage due to traditional habits, which is driving the growth of the market in the present period, as per industry observation. How will the Drink Segment Expand Rapidly During 2025-2034? The drink segment is estimated to register rapid expansion during the forecast period due to its excellent characteristics like faster absorption, convenience, and on-the-go consumption facilities. Several nootropic ingredients, such as L-theanine, caffeine, and others, are actively seen in gaining immense attention from the younger generation, which is expected to lead the segment growth in the upcoming years. Moreover, factors such as the fast-paced and modern lifestyle are contributing to the segment's potential in the current phase. Become a valued research partner with us - By Distribution Channel, The offline segment dominated the market with the largest share in 2024. The offline channels, such as health stores, pharmacies, and supermarkets, remain key sales points for nootropics. These locations allow customers to get expert advice, see physical products, and make instant purchases. Many customers still prefer in-person purchases due to trust and habit. Retailers also offer bundled promotions and loyalty benefits, which boost foot traffic. The online segment is expected to grow at a significant rate due to increasing digital adoption, easy product comparison, and greater availability of global brands. E-commerce allows consumers to browse a wide range of nootropic supplements, read reviews, and access educational content before purchasing. Subscription models and influencer marketing have also accelerated growth. The convenience of doorstep delivery and targeted advertising helps brands connect with consumers more effectively. Recent Developments The first nootropics food lab in Canada was established in January 2025 by Raymond Thomas, a biology professor at Western University. The lab creates brain-boosting meals by fusing Western science with Indigenous dietary expertise. To promote brain health through functional meals, Thomas and his colleagues will develop novel dishes in collaboration with an in-house chef and utilize biochemistry and metabolomics to assess their cognitive effects. In February 2025, the Scientific Advisory Board and Research Snapshot sections were launched by Nootropics Depot to increase openness and confidence in the supplement sector. The new advisory board will supervise product formulations and study evaluations to guarantee the highest levels of safety and efficacy. It will include specialists in integrative medicine, fitness, plant biology, and ethnobotany. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes schedule a call today: Nootropics Market Key Players Nootropics Depot Kimera Koffee Alternascript Cephalon LLC Teva Pharmaceuticals Onnit Powder City Mental Mojo Llc Mind Lab Pro Purelife Bioscience Company Ltd TruBrain Noocube Browse More Insights of Towards Healthcare: The global liquid biopsy IVD market was valued at US$ 2.21 billion in 2024 and is expected to reach US$ 2.54 billion in 2025. Projections indicate the market will grow to approximately US$ 8.72 billion by 2034, registering a CAGR of 14.79% during the forecast period. The liquid biopsy tube market stood at US$ 1.34 billion in 2024, rising to US$ 1.54 billion in 2025, and is anticipated to reach US$ 5.32 billion by 2034, expanding at a CAGR of 14.85% from 2025 to 2034. The specialty medical chairs market is valued at USD 5.12 billion in 2025 and is projected to climb to around USD 9.77 billion by 2034, growing at a CAGR of 7.43% over the forecast period. The biosensors market was valued at USD 30.04 billion in 2024, increasing to USD 32.64 billion in 2025, with expectations to reach USD 68.72 billion by 2034 at a CAGR of 8.64% from 2025 to 2034. The stem cell therapy market was worth USD 490 million in 2024, grew to USD 613.7 million in 2025, and is projected to reach around USD 4,777.40 million by 2034, expanding at a notable CAGR of 25.26% between 2025 and 2034. The home healthcare market is forecast to expand from USD 226.92 billion in 2025 to USD 476.80 billion by 2034, recording a CAGR of 8.6% over the analysis period. The regenerative medicine market is set to surge from USD 24.39 billion in 2025 to USD 139.70 billion by 2034, achieving a robust CAGR of 21.4%. The mice model market was valued at US$ 1.57 billion in 2024, increased to US$ 1.73 billion in 2025, and is expected to reach approximately US$ 4.1 billion by 2034, registering a CAGR of 10.04% during the forecast timeframe. The cancer biopsy market stood at US$ 30.81 billion in 2024, grew to US$ 36.61 billion in 2025, and is projected to soar to about US$ 163.29 billion by 2034, expanding at an impressive CAGR of 18.84% between 2025 and 2034. Meanwhile, the in vivo CAR-T platform market is gaining momentum worldwide, with expectations of generating hundreds of millions in revenue during the 2025–2034 period. Segments Covered in The Report By Form Capsules/Tablets Powder Drinks Others By Distribution Channel Offline Online By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Immediate Delivery Available | Buy This Premium Research @ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region - +44 778 256 0738 North America Region - +1 8044 4193 44 Web: Find us on social platforms: LinkedIn | Twitter | InstagramErreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données

Dialogue to Launch Comprehensive Women's and Family Health Care
Dialogue to Launch Comprehensive Women's and Family Health Care

Yahoo

time2 hours ago

  • Yahoo

Dialogue to Launch Comprehensive Women's and Family Health Care

A new standard of care, with access to trained clinicians in minutes MONTREAL, Aug. 14, 2025 /CNW/ - Dialogue Health Technologies Inc. ("Dialogue"), Canada's premier virtual healthcare and wellness platform, announced the upcoming launch of a comprehensive Women's and Family Health offering. Fully built in-house and seamlessly integrated within its platform, this new service deepens Dialogue's ongoing commitment to supporting the health needs of all women, through every stage of life. The rollout will commence in January 2026, beginning with specialized menopause care, which addresses a critical need in women's healthcare. Dialogue's innovative Women's and Family Health offering will provide evidence-based, whole-person care from trusted women's health clinicians, supporting all women and families through life's most important transitions. This program will offer employees and their dependents access to an in-house team of multidisciplinary clinicians trained in women's health, along with coaching and navigation support, personalized care plans, and educational resources, all delivered through Dialogue's Integrated Health Platform. "Women's health has always been a priority at Dialogue, and this launch marks an important step towards delivering more inclusive, targeted care that meets the diverse needs of women and their families," said Swati Matta, Head of Women's Health at Dialogue. "This isn't just an expansion of our services, it's a reflection of our commitment to ensure all women have access to timely, comprehensive care that is centred on their unique needs." Inequities in women's health affect a broad and diverse population, often intensified by intersecting factors such as race, ethnicity, income, disability, and geography. Many in these groups experience conditions that are poorly understood, underfunded, or overlooked. According to the World Economic Forum and McKinsey Health Institute's 2024 report, part of this is due to inadequate training for healthcare practitioners in understanding and addressing gender-specific health conditions, but also in recognizing how common diseases can present and respond differently in women. Menopause will be the first area of focus. 3 in 4 women experience menopause symptoms that interfere with their daily lives, such as hot flashes, sleep disturbances, mood changes, and cognitive challenges, causing 1 in 10 to leave the workforce. These services will be delivered by Dialogue clinicians who will complete robust training, including attending the scientific conference organized by the Menopause Society of Canada. This forms the foundation of a specialized menopause care program, developed with oversight from Dialogue's medical team to ensure that care is evidence-based, patient-centred, standardized, monitored, and continuously improved. "We recognize the very real needs in women's health, and I'm proud to see Dialogue taking meaningful, proactive steps to close them. Providing healthcare practitioners with evidence-based education on perimenopause and menopause is essential to ensuring that all women receive the comprehensive care they deserve," shares Dr Stephanie Moynihan, Assistant Medical Director at Dialogue. "As a physician, I've seen firsthand how vital it is to offer care that addresses the full picture: physical, mental, and emotional, rather than treating issues in isolation. This is a critical step forward." Reducing stigma around women's health, especially in the workplace, begins with a more integrated and inclusive approach to care. As expectations around employee well-being continue to grow, companies must move beyond one-size-fits-all solutions and take a more meaningful approach to well-being. About Dialogue Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through its team of health professionals, it serves employers and organizations who have an interest in the health and well-being of their employees, members and their families. Dialogue's Integrated Health Platform™ is a one-stop healthcare hub that centralizes all programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet. Dialogue is the first virtual care provider to receive Accreditation with Exemplary Standing from Accreditation Canada, a third-party validation of safety and the highest-level quality of care. In October 2023, Sun Life acquired Dialogue, which now operates as a standalone entity as part of Sun Life Canada. For more information, please visit the Company's website at SOURCE Dialogue Health Technologies Inc. View original content to download multimedia:

New Report Shows Integrated Digital Care Breaking Through Barriers to Mental Health for Young Canadians
New Report Shows Integrated Digital Care Breaking Through Barriers to Mental Health for Young Canadians

Yahoo

time3 hours ago

  • Yahoo

New Report Shows Integrated Digital Care Breaking Through Barriers to Mental Health for Young Canadians

TORONTO, Aug. 14, 2025 /CNW/ - A new report from GreenShield reveals that digital care is transforming mental health outcomes for young Canadians. At the heart of this transformation is GreenShield+, a first-of-its-kind digital health and benefits platform that brings health coverage and care together in one seamless experience. According to GreenShield's new Health Outcomes Report: Measuring Better Health for All, more than half of Canadians under 35 who accessed digital therapy through GreenShield+ recovered from symptoms of anxiety (52%) and depression (51%)—after just three sessions. As youth mental health challenges continue to rise, the report highlights how combining health services and benefits into one integrated experience is driving real, measurable improvements. "Young Canadians are telling us—through both data and lived experience—that the current system isn't consistently meeting their needs," said Zahid Salman, President and CEO of GreenShield. "This report affirms what drives us at GreenShield: the future of health care must be integrated, inclusive, and accountable. By uniting coverage and care into one seamless experience, we're not just improving access – we're improving health outcomes for Canadians of all ages." Key insights: Young Canadians are Engaged: In Q2 2025, nearly 800,000 claims and appointments were handled through GreenShield+. Almost 1 in 3 users were under 35, showing strong demand among younger Canadians. Faster Relief Through Virtual Care: Within GreenShield+, 92 per cent of health issues were resolved in a single virtual health care visit, offering frictionless access for Canadians balancing work, school and life. Digital Cognitive Behavioural Therapy (CBT) Works: After just three sessions of digital CBT, over half of users under 35 reported recovery from symptoms of anxiety (52%) and depression (51%). Smart Therapist Matching: The advanced therapist-matching tool in GreenShield+ helps users access a counsellor within 24 hours, with a 93 per cent satisfaction rate. Better Medication Adherence: GreenShield delivered 6 per cent higher medication adherence rates than industry averages, including adherence rates of 92 per cent for asthma and 84 per cent for mental health medications. "Integrated digital care is fundamentally reshaping mental health outcomes for Canadians—not only by expanding access to services, but by delivering care that is personalized, data-informed, and responsive to individual needs," said Dr. Andrew Bond, Senior Vice President and Chief Medical Officer at GreenShield. "The findings in our report reaffirm our conviction that when care systems are connected and coordinated, they don't just improve outcomes—they empower people, strengthen communities, and transform lives." A national commitment to youth mental health As Canada's only national non-profit health and benefits company, GreenShield is doubling down on its mission of Better Health for All. Earlier this year, it launched a new social impact initiative focused on transforming youth mental health care for Canadians aged 15 to 29. A cornerstone of this initiative is GreenShield's Youth Mental Health Data Hub, Canada's most comprehensive resource providing diverse datasets on youth mental health, developed in partnership with Mental Health Research Canada. The Hub provides real-time insights, available free of charge to inform policy, research, and care delivery Later this year, GreenShield will launch a comprehensive youth mental health solution, designed to tackle the biggest barriers young people face: care navigation, equitable access, and affordability. By uniting coverage and care in one platform, GreenShield is not just supporting youth more effectively—it's redefining what's possible for the next generation. Coverage and care, all in one place Canadians spend 2.5 times more time navigating health care and benefits than actually receiving care. GreenShield+ is changing that. As the first-of-its-kind digital health and benefits ecosystem, GreenShield+ streamlines the health care journey, bringing health benefits and health care services including mental health services, telemedicine, pharmacy and chronic disease management into one integrated and easy-to-use platform. With GreenShield+, users can check coverage, access care, and get reimbursed—all in one place. It's a simpler, smarter way to support better health that helps Canadians spend less time navigating the healthcare system and more time taking care of their health. To read GreenShield's full Health Outcomes Report, visit: About GreenShield As Canada's only national non-profit health and benefits company, GreenShield believes health care is a right, not a privilege. We're dedicated to improving health outcomes, driving systemic change, and building a future where every Canadian can reach their full health and well-being potential. We are revolutionizing the health and benefits experience with coverage and care in one place. Through our unique integrated payer-provider ("payvider") model, we offer insurance, administer benefits and pay claims as a 'payer' while offering health services such as mental health, pharmacy, telemedicine and chronic disease management as a 'provider'. As a non-profit social enterprise without shareholders, we prioritize and reinvest our excess earnings to directly support underserved communities. Through GreenShield Cares, we've committed $75 million to improve the health of over one million Canadians by the end of 2025, focusing on mental health, essential medicines, and chronic disease management. Our scalable initiatives deliver meaningful change in pursuit of Better Health for All. GreenShield is proud to be recognized as one of Canada's Most Admired Corporate Cultures, a leading Imagine Canada Caring Company, and named on the Fortune's Change the World List. SOURCE GreenShield View original content to download multimedia: Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store